Advancements in Vaccines and Therapeutics

Recent advancements in vaccines and therapeutics have revolutionized disease prevention and treatment. mRNA vaccines, such as those developed by Pfizer-BioNTech and Moderna for COVID-19, use genetic material to prompt cells to produce proteins that elicit an immune response. These vaccines offer advantages like rapid development and broad applicability. Vector-based vaccines, such as those by Oxford-AstraZeneca and Johnson & Johnson, use harmless viruses to deliver pathogen genes into cells, stimulating an immune response. Thermostable vaccines, which remain effective at higher temperatures, are being developed for diseases like COVID-19 and malaria to improve distribution. Therapeutic advancements include monoclonal antibodies, which target specific proteins on pathogens or diseased cells, and antiviral drugs that inhibit viral replication. These innovations improve treatment efficacy and accessibility, advancing our ability to combat various diseases and conditions.

    Related Conference of Advancements in Vaccines and Therapeutics

    November 21-22, 2024

    7th Pathology and Infectious Disease Conference

    Dubai, UAE
    November 28-29, 2024

    20th World Congress on Infection Prevention and Control

    Paris, France
    March 13-14, 2025

    9th International Conference on Rare Diseases

    Prague, Czech Republic
    March 17-18, 2025

    12th International Congress on Infectious Diseases

    Berlin, Germany
    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands

    Advancements in Vaccines and Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in